Predictors of Response to Iron and Erythropoietin Stimulating Agents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.
Also called NCT03658876
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 197 participants
- Sponsor
- Registry
-
NCT03658876
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT03658876. Randomized; no masking; primary purpose diagnostic. Start 2015-06-03 (actual); primary completion 2016-12-31 (actual). Results posted on 2019-07-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Predictors of Response to Iron and Erythropoietin Stimulating Agents
- Acronym
- PRIME
- Condition
- Renal Failure Chronic
- Condition
- Anemia
- Intervention (Drug)
- Iron Sucrose Solution for Injection
- Intervention (Drug)
- Epoetin Beta
- Lead sponsor
- Imperial College London
Record details
- Record id
cardio:ct-nct03658876- Content hash
6dce0ad2a2681e3336afcd782997d3f749df5530009d809a01bb0c9dba94d520